From prior authorization to patient navigation to treatment management, AI is already reshaping how care is delivered in oncology practices today. This panel skips the buzzwords and puts real AI solutions on display, with live demos from companies bringing AI to the frontlines of cancer care.

This session is sponsored by: Canopy Care, DeepScribe, SamaCare, and TailorMed

In the swiftly evolving landscape of the post-pandemic era, a rapidly aging population, technological leaps, and new non-traditional healthcare players promise to create a radical shift in healthcare. Tom's keynote address, based on insights from his forthcoming book, "Gigatrends," delves into six major trends – including advancements in AI, the role of virtual health, shifting generational attitudes towards healthcare delivery. 

Tom will explore how these Gigatrends demand agility, creativity, and innovation from healthcare industry and its leaders. He'll offer valuable foresight on how to avoid the challenges and high costs of episodic care and the anonymity of many underserved patients.

Most of all, Tom's keynote will provide a thought-provoking perspective on how to change healthcare's social narrative from one that focuses only on cost to one that is value-based and which focuses on how healthcare can amplify GDP and our overall economic health.  Attendees will leave with a compelling vision of the future and tangible strategies to lead in this new era of healthcare.

Prepare to be challenged, inspired, and equipped with the necessary knowledge to navigate and embrace the unprecedented changes of healthcare's Gigatrends.

Receive a high-level overview of the current health care landscape, focusing on the key trends, policies, and innovations shaping cancer care. Plus, gain insights into the evolving priorities of payers, providers, policymakers, and patients—and what these shifts mean for oncology stakeholders today.

JCP Clinical Pathways Category: Infrastructure & Innovation

Explore the strategies, challenges, and benefits of integrating pharmacists into the operational framework of pathways across networks, highlighting their critical role in driving outcomes throughout clinical, financial, and operational domains.

JCP Clinical Pathways Category: Business

Supported by an educational grant from Johnson & Johnson.

These accredited educational sessions offer a comprehensive look into the rapidly evolving healthcare landscape, providing the knowledge and skills necessary to thrive in a value-based care environment in which clinical pathways are a key component to driving precision and optimization of patient care.

Discover how emerging treatments—from bispecific antibodies and CAR T-cell therapy to radiopharmaceuticals and theranostics—are implemented in outpatient and community settings. This topic highlights key infrastructure needs, operational strategies, and real-world insights for adapting to the evolving therapeutic landscape. 

JCP Clinical Pathways Category: Infrastructure & Innovation 

This session is sponsored by Pfizer.

The rapidly changing landscape of radiopharmaceuticals will lead to an evolution, if not a revolution, in the way we approach cancer care. Specialists in radiology, interventional radiology, radiation oncology, and medical oncology will certainly be part of the delivery of pharmaceuticals, but it’s not entirely clear, how the specialties will work together. Questions include sequencing, the use of compatible and supportive technologies, as well as the administration of radiopharmaceuticals and follow up in surveillance going forward.

The panel will provide a baseline of knowledge about the present and future of radiopharmaceuticals in oncology care, and then engage panel discussion including radiation oncology, interventional oncology, and medical oncology, in a discussion about how the promise of radiopharmaceutical might be realized, not only in therapy administration, but in the context of holistic oncology care.

JCP Clinical Pathways Category: Infrastructure & Innovation

In this session, we’ll take a candid look at the real-world integration of AI technology in oncology care—focusing on the clinician experience. We’ll examine how AI tools enhance clinical documentation, democratize information, and improve decision-making processes in oncology care. This discussion will feature perspectives from both tech leaders building AI tools and the end-users applying them in everyday oncology care.

JCP Clinical Pathways Category: Infrastructure & Innovation

Join us in the Exhibit Hall to network with our exhibitors, sponsors, and fellow attendees as we celebrate the 10th Anniversary of the Journal of Clinical Pathways!

This session is sponsored by AbbVie.

Explore AI applications in operational efficiencies across the care continuum, focusing on practical implementations.

JCP Clinical Pathways Category: Infrastructure & Innovation

This session will delve into the insights gathered from a recent survey of clinical oncology pathway users and developers. By highlighting key findings and fostering an interactive discussion, the session aims to explore how collaborations between pharmaceutical companies, pathway developers, and health care providers can enhance patient outcomes and optimize care delivery.

JCP Clinical Pathways Category: Business

Engage in a dynamic debate on the impact of real-world evidence (RWE) in oncology care. Experts will argue whether RWE truly influences clinical decision-making and treatment pathways, comparing its strengths and limitations to traditional clinical trial data. This session will challenge assumptions and explore the potential of RWE to transform oncology practice, offering attendees a thought-provoking examination of its true value in cancer care.

JCP Clinical Pathways Category: Outcome Measurements

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

These accredited educational sessions offer a comprehensive look into the rapidly evolving healthcare landscape, providing the knowledge and skills necessary to thrive in a value-based care environment in which clinical pathways are a key component to driving precision and optimization of patient care.

The Predictable Cost of Care (PCOC) Working Group is a multi-stakeholder panel developing new industry standards for economic models, including a wider range of treatment-related costs to guide pathway decisions. This session will provide an update on the work PCOC is doing, including exciting findings and patient metrics collected during Phase 2 of their working group.

JCP Clinical Pathways Category: Business 

This session is sponsored by Johnson & Johnson.

Explore the integration of social, financial, and logistical needs into clinical pathways, focusing on the importance of developing care models that incorporate these elements into existing workflows. This session aims to provide a foundational understanding of how comprehensive care needs can be effectively integrated into clinical practice.

JCP Clinical Pathways Category: Business

This session explores strategies to extend patient support and care management beyond the clinic, focusing on coordinated, whole-person care. Attendees will learn how health systems can create more connected, patient-centered experiences that improve outcomes across the cancer care journey.

JCP Clinical Pathways Category: Infrastructure & Innovation